TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan · Delayed Price · Currency is TWD 7.70
+0.03 (0.39%)
Feb 11, 2026, 2:22 PM CST
TaiwanJ Pharmaceuticals Company Description
TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.
The company develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthma.
Its products target various diseases that include liver inflammation/liver fibrosis, non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, autoimmune diseases, asthma, and atopic dermatitis.
The company was incorporated in 2011 and is based in Zhubei, Taiwan.
TaiwanJ Pharmaceuticals Co., Ltd.
| Country | Taiwan |
| Founded | 2011 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Hung-Chang Yuan |
Contact Details
Address: No.2 ShengYi Road Zhubei, 302058 Taiwan | |
| Phone | 886 3 658 7721 |
| Website | taiwanj.com |
Stock Details
| Ticker Symbol | 6549 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0006549009 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hung-Chang Yuan | GM and Director |
| Dr. Edwin Wu Ph.D. | Founder and Honorary Chairman |
| Zhi Jie Guo | Accounting Supervisor |